Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers
暂无分享,去创建一个
O. Mir | F. Goldwasser | R. Coriat | C. Brézault | B. Brieau | J. Dréanic | M. Dior | Marie-Anne Guillaumot | Marie Bréchon